Clinical Trials on Refractory Breast Carcinoma in Germany
Total 2240 results
-
Ludwig-Maximilians - University of MunichPierre Fabre LaboratoriesCompletedCarcinoma Breast Stage IVGermany
-
University Hospital TuebingenRecruitingBreast Carcinoma | Breast Carcinoma in SituGermany
-
SamanTree Medical SASt. Vincenz Krankenhaus GmbH, PaderbornCompletedBreast-Conserving Surgery | Breast Cancer - Ductal Carcinoma in Situ (DCIS)Germany
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
German Breast GroupCompleted
-
Pierre Fabre Pharma GmbHiOMEDICO AGCompletedMetastatic Breast Cancer | Non Small Cell Lung CarcinomaGermany
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
University of MagdeburgBoehringer IngelheimTerminated
-
AIO-Studien-gGmbHDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingChemo-refractory Colorectal CarcinomaGermany
-
iOMEDICO AGNovartis Pharmaceuticals; Arbeitsgemeinschaft fur Internistische OnkologieCompletedBreast Cancer Recurrent | HER2/Neu-negative Carcinoma of Breast | Hormone Receptor Positive Malignant Neoplasm of BreastGermany
-
Fondazione MichelangeloCompletedInvasive Ductal Breast CarcinomaSpain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
-
Kliniken Essen-MitteGerman Breast GroupCompletedEarly-Stage Breast CarcinomaGermany, Switzerland
-
University of JenaUniversity Hospital Erlangen; Labor Prof. PachmannRecruiting
-
West German Study GroupGlaxoSmithKlineTerminatedCarcinoma, Ductal, BreastGermany
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
University Hospital Schleswig-HolsteinUniversity of LuebeckActive, not recruitingEarly-Stage Breast CarcinomaGermany
-
Hannover Medical SchoolUniversity Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaboratorsUnknownDe Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in TransformationGermany
-
AstraZenecaGerman Adjuvant Breast Cancer GroupCompleted
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Immutep S.A.S.CompletedAdenocarcinoma Breast Stage IVNetherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
University of LeipzigCompleted
-
West German Study GroupCelgeneActive, not recruiting
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingTNBC - Triple-Negative Breast CancerGermany
-
photonamic GmbH & Co. KGTerminated
-
German Breast GroupCompleted
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
Universitätsklinikum Hamburg-EppendorfCompletedCarcinomas of the Esophagogastric JunctionGermany
-
German Breast GroupBoehringer IngelheimCompleted
-
Technical University of MunichEli Lilly and CompanyRecruitingBreast Cancer/ Metastatic Breast CancerGermany
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
University of JenaCompleted
-
iOMEDICO AGRoche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...CompletedMetastatic Breast CancerGermany
-
NovartisCompletedMetastatic Breast CancerGermany
-
Shenzhen Core Medical Technology CO.,LTD.Not yet recruiting
-
West German Study GroupSanofi; AmgenCompletedPrimary Breast Cancer | Her2 Non-overexpressingGermany
-
Kliniken Essen-MitteRecruitingBreast Cancer | Node-positive Breast CancerGermany
-
RWTH Aachen UniversityUniv.-Prof. Dr. med. F. KiesslingUnknown
-
Kliniken Essen-MitteRecruitingPrimary Breast CancerGermany
-
Prof. Wolfgang JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHActive, not recruiting
-
University Hospital TuebingenPaul Ehrlich Institute, Langen, GermanyCompletedMetastatic Breast CancerGermany
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
AstraZenecaCompletedPlatinum Refractory Extensive-Stage Small Cell Lung CarcinomaSpain, Poland, Hungary, Ukraine, Germany
-
RWTH Aachen UniversityRecruiting